Old and New anticoagulants: The beginning of a new era?
Use of coumarin and heparin for more than sixty years, has been an effective and powerfulmedical tool for treatment and prevention of thromboembolic diseases, tarnished nevertheless,by their little security and laboratory controls which are frequently needed. Such reasonsmake for an effective challe...
Main Authors: | Fidel Cáceres Loriga, Aida Crespo Guerra |
---|---|
Format: | Article |
Language: | Spanish |
Published: |
ECIMED
2011-01-01
|
Series: | Revista Cubana de Cardiología y Cirugía Cardiovascular |
Subjects: | |
Online Access: | http://www.revcardiologia.sld.cu/index.php/revcardiologia/article/viewFile/87/61 |
Similar Items
-
The novel anticoagulants: entering a new era
by: Swiss Medical Weekly
Published: (2009-02-01) -
Monitoring of Anticoagulant Activity of Dabigatran and Rivaroxaban in the Presence of Heparins
by: Aleksandra Jakimczuk, et al.
Published: (2022-04-01) -
A review of pharmacogenetics of anticoagulant therapy: Heparins, rivaroxaban, apixaban, and dabigatran
by: Ali Mohammed Abd Alridha, et al.
Published: (2022-01-01) -
Recommendations on the use of anticoagulants for the treatment of patients with heparin-induced thrombocytopenia in Switzerland
by: Lorenzo A. Alberio, et al.
Published: (2020-04-01) -
Are outpatient anticoagulation management services the wave of the future (again)?
by: Bethany Samuelson Bannow
Published: (2022-05-01)